Trial Profile
A Phase I/II Randomized Study of the Short-Term Effects of APOMINE Vs Placebo in Postmenopausal Women With Osteoporosis or Low Bone Mass
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs SR 45023A (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 04 Oct 2005 New trial record.